Mosaic ImmunoEngineering Inc.
CPMV· OTC
CPMVMosaic ImmunoEngineering Inc.
Filed May 20, 2026 · 10-Q · 50 days after period end · 0001683168-26-004152
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$175.35K | -$181.32K | -$288.49K | -$399.04K |
| EPS Diluted | -$0.02 | -$0.03 | -$0.04 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 20, 2026 · 50 d after period end
